Mycobacterium abscessus


Also found in: Wikipedia.

Mycobacterium abscessus

A rapidly growing mycobacterium, which is common water contaminant and culprit in chronic lung, middle ear, wound and other cutaneous infections in immunocompromised hosts.

My·co·bac·te·ri·um ab·scessus

(mīkō-bak-tērē-ŭm ab-sesŭs)
Fast-growing Mycobacterium species that causes respiratory and wound infections in humans
References in periodicals archive ?
Preclinical in vitro and in vivo studies have demonstrated the potency of SPR720 against clinically important mycobacteria, including NTM species Mycobacterium avium complex and Mycobacterium abscessus. In June 2019, SPR720 was the focus of an equity investment by the Novo REPAIR Impact Fund for up to $10 million.
Septic arthritis caused by Mycobacterium fortuitum and Mycobacterium abscessus in a prosthetic knee joint: case report and review of literature.
Most notably was the outbreak in Anaheim, California, where 72 healthy children, ages 2-12, were infected with mycobacterium abscessus, a similar bacteria to those causing tuberculosis and leprosy.
It is less common for an antibiotic-resistant gene to be identified as a diagnostic antigen with high specificity; however, it has been found that a high similarity homolog of the erm family is mainly restricted to the tuberculosis complex and limited species of Mycobacterium, including Mycobacterium abscessus and Mycobacterium bolletii.
Mycobacterium abscessus infections among patients of a pediatric dentistry practice--Georgia, 2015.
Extensive cutaneous Mycobacterium abscessus infection due to contaminated insulin delivery system.
Por otro lado, la secuenciacion del segmento del gen 16S indico la presencia de Mycobacterium abscessus y Dietzia timorensis, dos especies de bacterias dentro del orden Actinomycetales.
In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
Culture grew Mycobacterium abscessus which was sensitive to amikacin, linezolid and clarithromycin.
The company has received the grant to study the treatment of two pulmonary non-tuberculous mycobacteria infections - Mycobacterium avium and Mycobacterium abscessus - with the company's inhaled Linhaliq and Lipoquin products.

Full browser ?